TNF and inflammatory bowel disease: Anti-tumor necrosis factor (anti-TNF) agents have recently shown relative efficacy in patients with VEO-IBD, especially in patients with CD phenotype, although they are not effective in maintaining long-term remission in more than 20% of treated patients (6).